HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Pandemic-Driven Trends Show Strong Immunity Supplement Future, Elderberry A Current 'Darling'

Executive Summary

VMS, homeopathic and other natural producs firms couldn't plan for spike in demand from coronavirus 2019, but the pandemic provides information to continue riding heightened consumer interest to higher ongoing sales, researchers said in recent Council for Responsible Nutrition webinar.

You may also be interested in...



Bloom In US Demand For Immunity Supplements Prompts Abbott, Star Nutra And PRTCL Launches

Abbott expands Pedialyte children’s line with adult products including Immune Support beverage in response to consumer demands for nutritional supplements to support immune health; Star Nutra introduces gummy immunity supplements; and PRTCL has a women’s immune-boost product.

Vitamin D And COVID-19 Studies: Prevention Benefits Suggested By Chicago Research

A study with nearly 500 patients with vitamin D levels tested within a year before receiving COVID-19 tests found subjects deficient in the nutrient had 1.77 greater chance of testing positive. Researchers say RCTs are needed to determine if broad population interventions are necessary.

Spray Supplement Zinc Up Developed On Idea Of Providing Immunity ‘Barrier’ For First Responders

"We were seeing how important immune support is and that’s kind of the origination of the idea," says Nutritional Brands CEO Danna Pratte. "It really was sparked because of the conversation about first responders and their need for protection."

Related Content

Topics

UsernamePublicRestriction

Register

LL1135645

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel